arrow
Return

Predicting process design spaces for spray drying amorphous solid dispersions

delete2021-12-01
delete18
delete
OA
AI
S
Stefanie Dohrn
P
Pranay Rawal
C
Christian Luebbert
K
Kristin Lehmkemper
S
Samuel O. Kyeremateng *
M
Matthias Degenhardt
G
Gabriele Sadowski *
DOI:10.1016/j.ijpx.2021.100072delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Amorphous solid dispersions (ASDs) are commonly manufactured using spray-drying processes. The product quality can be decisively influenced by the choice of process parameters. Following the quality-by-design approach, the identification of the spray-drying process design space is thus an integral task in drug product development. Aiming a solvent-free and homogeneous ASD, API crystallization and amorphous phase separation needs to be avoided during drying. This publication provides a predictive approach for determining spray-drying process conditions via considering thermodynamic driving forces for solvent drying as well as ASD-specific API/polymer/solvent interactions and glass transitions. The ternary API/polymer/solvent phase behavior was calculated using the Perturbed-Chain Statistical Associating Theory (PC-SAFT) and combined with mass and energy balances to find appropriate spray-drying conditions. A process design space was identified for the ASDs of ritonavir and naproxen with either poly(vinylpyrrolidone) or poly(vinylpyrrolidone-co-vinylacetate) spray dried from the solvents acetone, dichloromethane, or ethanol.
Keywords:
Amorphous solid dispersion
Residual solvent
Spray drying
Solvent selection
PC-SAFT
Process design space
Crystallization
Glass transition
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

International Journal of Pharmaceutics cover
International Journal of Pharmaceutics
IF:
5.2
Papers:
2.2W
Citations:
6.7W

Organization

D
dortmund university of technology
Scholars:
9.4K
Papers: 9.1K
Citations: 15
A
AbbVie
Scholars:
7.4K
Papers: 3.7K
Citations: 23